179 related articles for article (PubMed ID: 8579968)
1. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Askanas V; Engel WK
Curr Opin Rheumatol; 1995 Nov; 7(6):486-96. PubMed ID: 8579968
[TBL] [Abstract][Full Text] [Related]
2. New advances in inclusion-body myositis.
Askanas V; Engel WK
Curr Opin Rheumatol; 1993 Nov; 5(6):732-41. PubMed ID: 8117535
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
Askanas V; Engel WK; Mirabella M
Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
[TBL] [Abstract][Full Text] [Related]
5. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging.
Askanas V; Engel WK
Scand J Rheumatol; 1998; 27(6):389-405. PubMed ID: 9855208
[TBL] [Abstract][Full Text] [Related]
6. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms.
Askanas V; Engel WK
Curr Opin Neurol; 2002 Oct; 15(5):525-31. PubMed ID: 12351995
[TBL] [Abstract][Full Text] [Related]
7. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 1998 Nov; 10(6):530-42. PubMed ID: 9812213
[TBL] [Abstract][Full Text] [Related]
8. Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.
Askanas V; Engel WK
J Neuropathol Exp Neurol; 2001 Jan; 60(1):1-14. PubMed ID: 11202170
[TBL] [Abstract][Full Text] [Related]
9. Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging.
Askanas V; Engel WK
Curr Opin Rheumatol; 2003 Nov; 15(6):737-44. PubMed ID: 14569203
[TBL] [Abstract][Full Text] [Related]
10. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
[TBL] [Abstract][Full Text] [Related]
11. Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging.
Askanas V; Engel WK
J Child Neurol; 2003 Mar; 18(3):185-90. PubMed ID: 12731644
[TBL] [Abstract][Full Text] [Related]
12. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
[TBL] [Abstract][Full Text] [Related]
13. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
Sarkozi E; Askanas V; Engel WK
Am J Pathol; 1994 Dec; 145(6):1280-4. PubMed ID: 7992832
[TBL] [Abstract][Full Text] [Related]
14. [Inclusion body myositis].
Serratrice G
Presse Med; 1996 Jun; 25(21):985-8. PubMed ID: 8692777
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology and pathogenesis of inclusion-body myositis.
Askanas V; Engel WK
Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
[TBL] [Abstract][Full Text] [Related]
16. Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.
Askanas V; Engel WK
Curr Rheumatol Rep; 2002 Oct; 4(5):427-33. PubMed ID: 12217248
[TBL] [Abstract][Full Text] [Related]
17. beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis.
Askanas V; Alvarez RB; Engel WK
Ann Neurol; 1993 Oct; 34(4):551-60. PubMed ID: 7692809
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
Vattemi G; Engel WK; McFerrin J; Askanas V
J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
[TBL] [Abstract][Full Text] [Related]
20. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
